Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(2 sites)
China
Chinese Academy of Medical Science and Blood Disease Hospital, Tianjin, Tianjin Municipality Institute of Hematology & Blood Diseases Hospital, Tianjin, Tianjin Municipality Last updated February 2025